Candriam SCA’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-95,955
Closed -$3.57M 822
2020
Q3
$3.57M Sell
95,955
-20,849
-18% -$826K 0.03% 405
2020
Q2
$5.99M Sell
116,804
-98,292
-46% -$4.11M 0.06% 300
2020
Q1
$12.5M Hold
215,096
0.14% 169
2019
Q4
$12.8M Buy
+215,096
New +$9.67M 0.14% 170
2018
Q4
Sell
-30,000
Closed -$1.33M 822
2018
Q3
$1.33M Hold
30,000
0.02% 575
2018
Q2
$1.18M Hold
30,000
0.02% 579
2018
Q1
$2.17M Sell
30,000
-55,000
-65% -$4.04M 0.04% 464
2017
Q4
$5.6M Buy
85,000
+5,000
+6% +$269K 0.1% 251
2017
Q3
$4.01M Buy
80,000
+10,000
+14% +$482K 0.07% 311
2017
Q2
$3.24M Buy
+70,000
New +$2.57M 0.06% 357
2016
Q4
Sell
-50,000
Closed -$693K 676
2016
Q3
$693K Hold
50,000
0.02% 549
2016
Q2
$494K Sell
50,000
-14,000
-22% -$232K 0.01% 551
2016
Q1
$1.08M Sell
64,000
-11,000
-15% -$177K 0.03% 417
2015
Q4
$1.67M Sell
75,000
-25,800
-26% -$651K 0.04% 325
2015
Q3
$2.38M Sell
100,800
-59,200
-37% -$3.72M 0.06% 314
2015
Q2
$13.1M Buy
160,000
+17,000
+12% +$1.66M 0.27% 103
2015
Q1
$13.2M Buy
143,000
+88,000
+160% +$5.68M 0.27% 103
2014
Q4
$2.22M Buy
+55,000
New +$1.68M 0.05% 346

Other funds holding ESPR